GWILX
Price
$16.76
Change
-$0.01 (-0.06%)
Updated
Oct 3 closing price
Net Assets
6.15M
RMEBX
Price
$62.45
Change
+$0.24 (+0.39%)
Updated
Oct 3 closing price
Net Assets
112.47B
Interact to see
Advertisement

GWILX vs RMEBX

Header iconGWILX vs RMEBX Comparison
Open Charts GWILX vs RMEBXBanner chart's image
Glenmede SMID Core Equity Advisor
Price$16.76
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets6.15M
American Funds American Mutual R2E
Price$62.45
Change+$0.24 (+0.39%)
VolumeN/A
Net Assets112.47B
GWILX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
GWILX vs. RMEBX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GWILX is a Buy and RMEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 112B vs. GWILX (6.15M). RMEBX pays higher dividends than GWILX: RMEBX (1.05) vs GWILX (0.69). GWILX was incepted earlier than RMEBX: GWILX (10 years) vs RMEBX (11 years). GWILX (1.16) is less costly to investors than RMEBX (1.07). GWILX is a more actively managed with annual turnover of: 80.00 vs. RMEBX (31.00). GWILX has a lower initial minimum investment than RMEBX: GWILX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 7.78 vs. GWILX (-1.31). RMEBX return over 5 years is better than : 62.31 vs. GWILX (28.74).
GWILXRMEBXGWILX / RMEBX
Total Expense Ratio0.851.0779%
Annual Report Gross Expense Ratio1.161.07108%
Fund Existence10 years11 years-
Gain YTD9.29414.62864%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.15M112B0%
Annual Yield % from dividends0.691.0566%
Returns for 1 year-1.317.78-17%
Returns for 3 years30.6937.9681%
Returns for 5 years28.7462.3146%
Returns for 10 yearsN/A95.56-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AARD16.080.71
+4.62%
Aardvark Therapeutics Inc
ARCB71.982.45
+3.52%
ArcBest Corp
SAIA297.423.52
+1.20%
Saia
TVACU11.29N/A
N/A
Texas Ventures Acquisition III Corp
PED0.58-0.01
-1.49%
PEDEVCO Corp